tirzepatide pdufa GLP-1 Pipeline Expands with New Molecules and Combinations | Eric Topol, MD posted on the topic Compounded GLP-1/GIP (Tirzepatide) - bmiMD

If you have any concerns about your medication or if you have other side effects that you think are caused by this medication, please consult your doctor or pharmacist

doi: 10.1007/s11136-005-8027-6 [DOI] [PubMed] [Google Scholar] 35

The limitations of this meta-analysis include the restricted number of included studies and their small sample sizes

[3] Sermorelin was originally approved in the 1990s for GH deficiency but was later discontinued as a commercial drug for business reasons (not due to safety or efficacy concerns)

The medication works through multiple complementary mechanisms

This change in taste is known as dysgeusia and reflects how the body responds to the medication rather than a harmful reaction